ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

pharmafile | February 23, 2011 | Appointment | Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing 

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim.

Kieran, who is currently head of GE Healthcare’s Life Sciences global commercial operations, will take up his new post on 1 April and Peter who will retire from GE after a transition period on 31 July.

GE Healthcare president and chief executive John Dineen said: “Peter is handing over the Life Sciences business to Kieran in great shape, with record 2010 results, a strong portfolio and ambitious growth plans. We thank Peter for his leadership, his 28-year contribution to the business, and we look forward to a smooth transition into Kieran’s hands.

“Our Life Sciences business is a key part of GE Healthcare and its strategy. Peter has been instrumental in growing and reshaping it since taking charge in 2006. Kieran’s energy, imagination and commercial focus make him ideally suited to continue driving the business forward,” he added.

Kieran joined GE upon its acquisition of Whatman, where he was chief executive, in 2008.

His pharma career, which spans more than 20 years, began at Janssen and encompassed roles at Mallinckrodt, veterinary medicines business Vericore, Adprotech, Innovata and Novartis.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content